Assembly Biosciences, Inc.

Assembly Biosciences, Inc. (Assembly Bio) is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. It develops innovative small-molecule antiviral therapeutics targeting serious viral and liver diseases, with clinical programs for recurrent genital herpes (long-acting helicase-primase inhibitors), chronic hepatitis delta virus (HDV), and chronic hepatitis B (HBV), plus research in cholestatic liver disease. Its mission is to change the treatment paradigm for patients with these devastating diseases.